Holen Sie sich die Stockscreener-App
21.83
0.22%
0.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt FMS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$21.79
Offen:
$21.89
24-Stunden-Volumen:
100.44K
Relative Volume:
0.36
Marktkapitalisierung:
$12.79B
Einnahmen:
$20.87B
Nettoeinkommen (Verlust:
$715.19M
KGV:
26.77
EPS:
0.8156
Netto-Cashflow:
$2.10B
1W Leistung:
+2.42%
1M Leistung:
+3.94%
6M Leistung:
+1.95%
1J Leistung:
+11.13%
1-Tages-Spanne:
$21.71
$22.00
1-Wochen-Bereich:
$21.42
$22.20
52-Wochen-Spanne:
$17.93
$22.76
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Firmenname
Fresenius Medical Care Ag Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie FMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| FMS | 21.84 | 12.79B | 20.87B | 715.19M | 2.10B | 0.8156 |
| HCA | 326.19 | 83.79B | 69.62B | 5.93B | 5.88B | 20.33 |
| THC | 146.90 | 14.83B | 20.97B | 3.13B | 2.39B | 4.33 |
| DVA | 163.47 | 13.19B | 12.67B | 827.68M | 1.42B | 5.03 |
| UHS | 196.60 | 13.03B | 15.42B | 1.03B | 956.84M | 9.53 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-08 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-11-17 | Hochstufung | Societe Generale | Hold → Buy |
| 2023-08-14 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-01 | Fortgesetzt | Citigroup | Neutral |
| 2023-07-12 | Eingeleitet | Goldman | Buy |
| 2023-03-07 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-01-03 | Herabstufung | Jefferies | Buy → Underperform |
| 2022-10-26 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-27 | Hochstufung | Jefferies | Underperform → Buy |
| 2022-02-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2021-11-23 | Eingeleitet | HSBC Securities | Hold |
| 2021-11-11 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-02-04 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-03 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-20 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | Hochstufung | Jefferies | Hold → Buy |
| 2019-06-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | Hochstufung | UBS | Neutral → Buy |
| 2018-08-28 | Hochstufung | HSBC Securities | Hold → Buy |
| 2018-07-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | Hochstufung | UBS | Sell → Neutral |
| 2017-12-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2016-07-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2016-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2015-11-04 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | Hochstufung | Goldman | Neutral → Buy |
| 2015-08-13 | Herabstufung | Societe Generale | Buy → Hold |
| 2015-07-31 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | Bestätigt | Feltl & Co. | Hold |
| 2013-01-14 | Hochstufung | HSBC Securities | Neutral → Overweight |
Alle ansehen
Fresenius Medical Care Ag Adr Aktie (FMS) Neueste Nachrichten
Blood Recovery Machine Market is expected to reach revenue of USD 4,277.4 Mn by 2033, at 5.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
Fresenius Medical Care Earnings: Margin Expansion Boosts 2024 Profit Outlook Toward Top End of Goal - Morningstar
Fresenius Medical Care ADR earnings beat by $0.35, revenue fell short of estimates - Investing.com India
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
Weekly Upgrades and Downgrades - InvestorPlace
2024 Healthcare Stocks List | Updated Daily - Sure Dividend
Saudi Arabia Generic Pharmaceutical Products Market Report 2024-2031, Featuring Profiles of Key Players - GlobeNewswire Inc.
FMS Stock Rides On Diversified Portfolio And Restructuring Initiatives - Barchart
Canada Clinical Laboratory Service Market Size & Outlook, 2030 - Grand View Research
Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar
The Best Healthcare Stocks to Buy - Morningstar
Expert Call - Fresenius Medical Care
Earnings call: Fresenius Medical Care sees steady progress in Q2 - Investing.com
Earnings call: Fresenius Medical Care confirms outlook, reports growth - Investing.com
Fresenius Medical Care Aims to Improve Its Margins Substantially - Morningstar
Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024 - Fresenius Medical Care
UK Clinical Laboratory Service Market Size & Outlook, 2030 - Grand View Research
Singapore Home Healthcare Market Size & Outlook, 2023-2030 - Grand View Research
Italy Home Healthcare Market Size & Outlook, 2023-2030 - Grand View Research
Fresenius Medical Care celebrates 50th anniversary of St. Wendel site - Fresenius Medical Care
Kidney Transplant Market to Grow at a 3.3% CAGR from 2024 to 2034, Fueled by Healthcare Spending and Renal ... - GlobeNewswire Inc.
Fresenius Medical Care: Significant Upside Remains (NYSE:FMS) - Seeking Alpha
Fresenius Medical Care (NYSE:FMS) Coverage Initiated by Analysts at StockNews.com - Defense World
Fresenius Medical Care AG (NYSE:FMS) Shares Acquired by GAMMA Investing LLC - Defense World
Finanzdaten der Fresenius Medical Care Ag Adr-Aktie (FMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
1.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):